StockData

Anteris Technologies Global vs Picard Medical

AVR and PMI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AVR and PMI compare

Anteris Technologies Global is the larger company, worth 33 times as much as Picard Medical ($556M against $16.9M).

Picard Medical grew revenue faster over the last twelve months (11.6% versus 9.0% for Anteris Technologies Global).

Picard Medical keeps more of each dollar of sales as profit, with a net margin of −371% compared with −4637% at Anteris Technologies Global.

Picard Medical scores higher on the StockData Score (6 against 5 for Anteris Technologies Global), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAVRPMI
Size and price
Market cap$556M$16.9M
Share price$5.70$7.24
Change, 1 year50.4%−94.1%
Beta (5Y)1.57−2.24
Employees17475
StockData Score
Total score56 (better)
Valuation score1 (better)0
Growth score12 (better)
Performance score00
Health score34 (better)
Dividend score00
Valuation
P/S238×3.2× (better)
P/B2.4× (better)12.7×
FCF yield−16.8%–
Fair value–$3.89
Margin of safety–−86.3%
Growth
Revenue growth (TTM)9.0%11.6% (better)
Profitability
Gross margin75.8% (better)26.2%
Operating margin−4880%−267% (better)
Net margin−4637%−371% (better)
FCF margin−4008%–
Return on equity−93.8% (better)−426%
Return on invested capital−3856%−351% (better)
Financial health
Debt / equity0.00 (better)0.00
Interest coverage−615.2×–
Current ratio12.45 (better)0.99
Altman Z-score6.59 (better)−17.56
Piotroski F-score15 (better)
Dividends and buybacks
Buyback yield–0.00%
Shareholder yield0.00%0.00%
Ownership
Held by institutions70.8%6.5%
Held by insiders32.6%–
Insider net buying, 12 months$44.1M–
Short interest, % of float13.8%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.